Read more here: Janssen Submits Application to the European Medicines Agency for RYBREVANT®▼ (amivantamab) in Combination with Chemotherapy for the First-Line...
Read more here: Janssen Submits Application to the European Medicines Agency for RYBREVANT®▼ (amivantamab) in Combination with Chemotherapy for the First-Line...
See the original post: LSL Pharma Group Engages Paradox as Investor Relations Services Provider
See original here: Immunocore announces upcoming presentation and posters at ESMO 2023
Originally posted here: FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for Treatment of Psoriasis in Children Ages 6 to 11
See the original post: Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
Original post: Locanabio Announces Presentation of Preclinical Data Demonstrating an Improved Vectorized snRNA Platform with Applications in Exon Skipping for the...
Original post: Aditxt, Inc. to Present at 8th Annual Dawson James Conference
See the article here: Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
Read the original: IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
More here: Bon Natural Life Limited Announces Signing MOU for Distributing Jiangwang Spirits in China
Recent Comments